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Background: Post-translational modifications 
of collagen have only been found in animals so 
far. 
Results: The L230 ORF of Mimivirus encodes a 
bifunctional collagen lysyl-hydroxylase/ 
glucosyltransferase enzyme. 
Conclusion: Collagen, and the machinery for its 
post-translational modification is present in 
Mimivirus. 
Significance: Collagen modifications are not 
restricted to the domains of life. 
 
SUMMARY 
Collagens, the most abundant proteins in 
animals, are modified by hydroxylation of 
proline and lysine residues, and by 
glycosylation of hydroxylysine. Dedicated 
prolyl-, lysyl hydroxylase and collagen 
glycosyltransferase enzymes localized in the 
endoplasmic reticulum mediate these 
modifications prior to the formation of the 
collagen triple helix. Whereas collagen-like 
proteins have been described in some fungi, 
bacteria, and viruses, the post-translational 
machinery modifying collagens has never 
been described outside of animals. We 
demonstrate that the L230 open reading 
frame of the giant virus Acanthamoeba 
polyphaga Mimivirus encodes an enzyme 
including distinct lysyl hydroxylase and 
collagen glycosyltransferase domains. We 
show that Mimivirus L230 is capable of 
hydroxylating lysine and glycosylating the 
resulting hydroxylysine residues in a native 
Mimivirus collagen acceptor substrate. 
Whereas in animals from sponges to humans 
the transfer of galactose to hydroxylysine in 
collagen is conserved, the Mimivirus L230 
enzyme transfers glucose to hydroxylysine, 
thereby defining a novel type of collagen 
glycosylation in nature. The presence of 
hydroxylysine in Mimivirus proteins was 
confirmed by amino acid analysis of 
Mimivirus recovered from Acanthamoeba 
polyphaga cultures. This work shows for the 
first time that collagen post-translational 
modifications are not confined to the domains 
of life. The utilization of glucose instead of the 
galactose found throughout animals, as well 
as a bifunctional enzyme rather than two 
separate enzymes, may represent a parallel 
evolutionary track in collagen biology. These 
results suggest that giant viruses may have 
contributed to the evolution of collagen 
biology. 
 
INTRODUCTION 
Collagens are the most abundant animal 
proteins, acting not only as a scaffold for tissue 
but also as regulators of many biological 
processes, including cell attachment, 
proliferation, and differentiation (1). Mainly 
linear proteins, collagens are characterized by 
domains composed of Gly-X-Y repeats, with Pro 
and Lys often present at positions X and Y. 
Nascent pro-collagen polypeptides are post-
translationally modified beginning with the 
hydroxylation of selected Pro (2) and Lys (3) 
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residues. Some hydroxylysine (Hyl) residues are 
subsequently modified by addition of 
carbohydrates forming the disaccharide Glc-
1,2-Gal-1,O-Hyl (4-5). The extent of 
glycosylation can vary with tissue distribution 
and the type of collagen. The presence of 4-
hydroxyproline (Hyp) is essential for collagen 
triple helix formation and thermal stability (6). 
Lys hydroxylation produces substrates for 
glycosylation reactions and is also important for 
the cross-linking of collagen fibrils. The 
biological significance of collagen post-
translational modifications is reflected in the 
diseases associated with defective collagen 
modifications. Mutation of the lysyl hydroxylase 
genes PLOD1, PLOD2 and PLOD3 cause 
Ehlers-Danlos type-VI (7), Bruck syndrome (8), 
and a form of skeletal dysplasia (9), 
respectively.  
The GLT25D1 and GLT25D2 genes 
encoding collagen galactosyltransferase 
(ColGalT) enzymes were only recently 
identified (10). Whole genome RNA 
interference studies in Caenorhabditis elegans 
suggest that loss of ColGalT is associated with 
severe phenotypes like slow growth, abnormal 
locomotion, and sterility (11). Interestingly, non- 
fibrillar proteins with collagen domains such as 
the hormone adiponectin (12), the mannose-
binding lectin (13), and the acetylcholine 
esterase complex (14) also contain glycosylated 
Hyl. The collagen domains of these proteins are 
involved in protein folding and oligomerization 
making it likely that the glycan chains are 
involved in this process as well.  
Collagens and collagen-like proteins are 
not confined to animals. Some fungi such as 
Metarhizium anisopliae (15), and bacteria such 
as Streptococcus pyogenes (16-17) express 
collagen-like proteins. However, apart from a 
few proteins in bacteriophages (18-20), no 
collagen-like proteins in viruses have been 
reported. Little is known about collagen-like 
proteins in bacteria, fungi, and phages, and none 
of these proteins has been characterized for the 
common collagen post-translational 
modifications that are necessary for proper 
triple-helix formation. The first evidence 
suggesting viruses might code for their own 
glycosyltransferase genes rather than relying 
solely on host cell machinery was described in 
the Paramecium bursaria chlorella virus (21). 
More recently, reported genome sequences of 
viruses such as the shrimp White Spot Syndrome 
Virus (22), Lymphocystis Disease Virus (23), 
the Acanthamoeba polyphaga Mimivirus (24), 
and two virophages called Sputnik (25) and 
Organic Lake Virophage (26), suggested that 
viruses possess collagen-like proteins as well as 
collagen modifying enzymes. 
 
EXPERIMENTAL PROCEDURES 
Cloning of expression vectors – The 
pET16b-L230 expression vector was created by 
first isolating Mimivirus genomic DNA 
according to Raoult et al. (24). The L230 gene 
was amplified from the genomic DNA by PCR 
with the primers 5’-GACCCATGGGA-
TCCATTAGTAGAACTTATGTAAT-3’ and 
5’-GTCACTAGTTTAATTAACAAAAGACA-
CTAAAATAT-3’ (Microsynth, Balgach, 
Switzerland). The amplification primers 
incorporated a 5’ NcoI and a 3’ SpeI restriction 
endonuclease site respectively which were used 
to clone the fragment into the plasmid pFastBacI 
(Invitrogen, Basel, Switzerland). The L230 gene 
was subsequently amplified by PCR using the 
pFastBac construct as template, and the primers 
5’-TGACCTCGAGATTAGTAGAACTTATG-
TAATT-3’ and 5’-CAGGGATCCGTCCAATA-
AAGTGTATCAAC-3’ incorporating a 5’ XhoI 
site and a 3’ BamHI site into the amplicon. The 
XhoI/BamHI digested amplicon was then ligated 
into XhoI/BamHI digested pET16b (Merck, 
Geneva, Switzerland) vector. 
Northern blots – Acanthamoeba poly-
phaga cells were infected with Mimivirus and 
RNA was isolated at 0, 4, 8, 16, and 24 hours 
post infection.  For each sample, 2.5 g of RNA 
was separated on a 1% formaldehyde agarose 
gel and transferred to a nylon Hibond-N 
membrane (GE Healthcare Biosciences AB, 
Uppsala, Sweden). The probes were amplified 
by PCR using Mimiviral genomic DNA with the 
primers shown in Supplemental Table 2. Probes 
were labelled with [32P]dCTP (Hartmann 
Analytic, Braunschweig, Germany) by random 
priming (Agilent, Basel, Switzerland). The 
membranes were incubated for 2 h at 80°C and 
prehybridized for 1 h at 64°C with QuikHyb 
hybridization solution (Agilent, Basel, 
Switzerland) containing 100 g/mL ultra pure 
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herring sperm DNA (Invitrogen, Basel, 
Switzerland). Hybridization was performed 
overnight at 64°C using 5 × 105 cpm of labelled 
probe per mL of hybridization solution. 
Membranes were washed in 0.1 × SSC, 0.1% 
SDS and incubated in a 75°C water bath until 
the temperature of the solution reached 60°C.  
The washed membranes were exposed on Kodak 
BioMax XAR film (Sigma-Aldrich Chemie, 
Buchs, Switzerland) for 24 h at room 
temperature. 
Baculovirus expression – Six well tissue 
culture plates were seeded with 2× 106 
Spodoptera frugiperda 9 (Sf9) cells per well. 
Cells were allowed to attach to the plate and 500 
L of Grace’s Insect Cell Media containing 
9.1% fetal calf serum was added to each well. A 
160 L aliquot of virus stock was added to each 
well to be infected and incubated for 1 h at 
28°C. Media was removed and replaced with 2 
mL of fresh media. Cells were incubated at 28°C 
for 3 days. After 3 days, cells were loosened 
from the plate with a cell scraper and moved to a 
microcentrifuge tube. Cells were pelleted and 
the supernatant removed and retained as a viral 
stock. The cell pellet was washed with 150 L 
of TBS (50 mM Tris-HCl, 138 mM NaCl, 2.7 
mM KCl) pH 7.4. The cells were lysed with 150 
L of TBS + 1% Triton X-100. The cell pellet 
was incubated on ice for 30 min with the lysis 
solution. Cell debris was removed by 
centrifugation and the supernatant retained as an 
enzyme stock. 
Bacterial expression – The pET16b-
based expression vector was transformed into 
chemically competent E. coli BL21(DE3) 
(Merck, Geneva, Switzerland) using a heat 
shock and a 1 h recovery step in 1 mL of 
antibiotic free lysogeny broth (LB) (27) with 
shaking at 220 rpm at 37°C. The next day, a 
fresh colony was inoculated into 50 mL of LB 
supplemented with 100 g/mL ampicillin 
(Sigma-Aldrich) (LBamp+) and incubated 
overnight at 37°C with shaking at 220 rpm. The 
next morning, 10 mL of the overnight culture 
was used to inoculate a 1 L culture of LBamp+ 
which was incubated at 37°C with shaking at 
200 rpm until an optical density at 600 nm 
(OD600) of approximately 0.4 was reached, at 
which point the temperature was lowered to 
32°C. When the OD600 approached 0.6, protein 
expression was induced with the addition of 
isopropylthio--D-galactopyranoside to a 
concentration of 1 mM. The culture was 
incubated for a further 3 h after which the 
bacteria were pelleted at 6000 × g at 4°C for 30 
min, and then resuspended in 30 mL of ice cold 
MCAC10 buffer (20 mM Tris-HCl pH 7.4, 500 
mM NaCl (Sigma-Aldrich), 10 mM imidazole 
(Sigma-Aldrich), 10% v/v glycerol (ERNE 
surface AG, Dällikon, Switzerland)) prior to 
freezing at -20°C. 
Protein purification – One 30 mL frozen 
pellet of transformed and induced E. coli 
BL21(DE3) was thawed and lysed under ice-
cold conditions using an Emulsiflex C5 French-
press (Avestin, Mannheim, Germany). The lysed 
bacteria were clarified by two consecutive 30 
min centrifugations at 13,000 × g at 4°C 
followed by filtration through a 0.22 m filter 
(Millipore, Zug, Switzerland) under vacuum. 
The protein was injected over a 1 mL HisTrap 
FF crude column (GE Healthcare) on an Äkta 
FPLC (GE Healthcare) at 1 mL/min. The 
column was washed with 10 column volumes of 
MCAC10 buffer containing 1 M NaCl, followed 
by 5 column volumes of MCAC10 to re-
equilibrate. The column was then washed with a 
5 column volume 10 mM to 100 mM gradient of 
imidazole at 1 mL/min. The column was eluted 
with a 20 column volume 100 mM to 500 mM 
gradient of imidazole at 1 mL/min. Eluates were 
immediately concentrated to 1 mL or less and 
buffer exchanged into MCAC10 using Amicon 
Ultra Centrifugal Filters (Millipore, Zug, 
Switzerland) with a nominal molecular weight 
cut-off of 30,000 Da, at 4000 × g in a swinging 
bucket rotor in a Heraeus Cryofuge 6000i 
centrifuge (Thermo-scientific, Geneva, 
Switzerland) at 4°C. The protein was stored in 
MCAC10 buffer at 4°C in the cold room for up 
to 1 week until needed. Samples for SDS-PAGE 
were prepared in 4 × loading buffer (200 mM 
Tris-HCl pH 6.8, 400 mM DTT (Sigma-
Aldrich), 8% w/v SDS (Sigma-Aldrich), 40% v/v 
glycerol, 4 mg/mL bromophenol blue (Merck). 
Ten L of sample in 4 × loading buffer was 
subjected to 10% SDS-PAGE. The gel was then 
stained with Coomassie blue R250 to visualize 
protein bands. 
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Lysyl hydroxylase assays – Lysyl 
hydroxylase assays were performed substantially 
as described in Kivirikko et al. (28). All 
solutions were kept on ice. Initiation of assays 
and all subsequent manipulations were 
performed in a fume-hood to prevent exposure 
to 14CO2.  Fresh stocks of 2 mM FeSO4 (Sigma-
Aldrich), 20 mM ascorbate (Sigma-Aldrich), and 
6 mM 2-oxoglutarate (Sigma-Aldrich) were 
prepared. Enzyme and acceptor substrate (either 
His10-tag purified, E. coli expressed L71 
Mimivirus collagen in MCAC10 buffer, or 
collagen-like peptide acceptors (GenScript, 
Piscataway, NJ, USA) dissolved in ddH2O) were 
added to each reaction tube. A master-mix of the 
remaining assay components was prepared, and 
aliquots of this were used to initiate each assay. 
The assay contained 50 nCi of 2-
[14C]oxoglutarate (Perkin Elmer, Schwerzen-
bach, Switzerland), 300 M 2-oxoglutarate, 100 
M FeSO4, 1 mM ascorbate, 50 mM Tris-HCl 
pH 7.4, and 100 M DTT. When peptide 
acceptor substrates were used, the assay 
contained 600 g/mL of peptide. Total assay 
volume was 100 L with the master-mix 
component comprising no less than half the total 
volume. Briefly, a small rectangular filter paper 
was soaked in NCS II Tissue Solubilizer (GE 
Healthcare) and suspended from a small hook in 
a rubber stopper. The top was cut from the 
microcentrifuge tube containing the enzyme and 
acceptor substrate which was then carefully 
lowered into a 30 mL scintillation vial (VWR, 
Dietikon, Switzerland). The assay was initiated 
by addition of the master mix, and the vial was 
immediately closed with the stopper allowing 
the soaked filter paper to absorb any radioactive 
14CO2 produced. The vial was incubated at 37°C 
for 1 h. The assay was stopped with 100 L of 
ice cold 1 M KH2PO4 administered into the 
reaction tube by a syringe and needle inserted 
through the stopper. The stopped assay was 
incubated for 30 min at room temperature, at 
which point the rubber stopper was removed and 
the filter paper transferred to a fresh scintillation 
vial. The filter paper was vortexed for 
approximately 5 s with 10 mL of IRGA-Safe 
Plus scintillation fluid (Perkin Elmer) and then 
measured in a Tri-Carb 2900TR scintillation 
counter (Perkin Elmer). 
Collagen glycosyltransferase assays – 
Glycosyltransferase assays were performed with 
bovine collagen type I or peptides as acceptor 
substrates substantially as described in Schegg et 
al. (10). Briefly, 20 nCi of UDP-[14C]Glc 
(Perkin Elmer) or UDP-[14C]GlcA (Perkin 
Elmer),  25 nCi of UDP-[14C]Gal (GE 
Healthcare) or UDP-[14C]GlcNAc (Perkin 
Elmer), or 50 nCi of UDP-[14C]GalNAc 
(American Radiolabeled Chemicals, St. Louis, 
USA) with a total UDP-sugar concentration of 
240 M were incubated with enzyme and 
substrate for 30 min at 37°C. The assay was 
stopped by incubation on ice with 5% 
phosphotungstic acid/5% trichloro-acetic acid 
for 30 min. The precipitate was recovered on 
filters using a vacuum manifold, and then 
scintillation counted. Total assay volume was 
100 L. Assays measuring the acceptor substrate 
specificity contained a total UDP-sugar 
concentration of 60 M, and utilized baculovirus 
produced L230 and GLT25D1 enzyme. The 
enzymes for this study could not be produced in 
E. coli as GLT25D1 will not express as a 
functional protein in that system. Baculovirus 
produced enzyme was prepared by lysing the 
cells and centrifuging the lysate to remove 
cellular debris. Double activity (lysyl 
hydroxylase plus collagen glucosyltransferase 
activity) assays utilized 20 nCi of UDP-[14C]Glc 
without additional UDP-Glc added 
(approximately 660 nM UDP-Glc).  E. coli 
produced, His10-tag purified Mimivirus L71 
protein was used as the acceptor substrate.  
Assays were incubated overnight at 4°C. 
Amino Acid Analysis – Aliquots of 10 
g of Mimivirus proteins were hydrolyzed in 4 
M NaOH for 48 h at 100°C. Amino acids were 
derivatized with Fmoc as described by Bank et 
al. (29) and analyzed by fluorescence detection 
after HPLC separation (10). Up to 100 L of 
sample was injected over an ODS Hypersil 150 
mm × 3 mm column with a 3 m particle size 
(Thermo-scientific).  Underivatized amino acids 
were also analyzed using the Dionex AAA-
Direct, high pH anion exchange chromatography 
system (Thermo-scientific).  Samples were 
diluted up to 300-fold prior to injection of 25 L 
over an AminoPac PA-10 column (Thermo-
scientific) using the following gradient: 0-8 min, 
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24% B; 8-11 min, 36% B; 11-25 min, 36% B; 
25-38 min, 20% B, 15% C; 38-47 min, 16% B, 
70% C; 47-57.1 min, 2% B, 95% C; 57.1-59.2 
min, 80% B; 59.2-90 min, 24% B.  All sections 
of this gradient used a convex gradient curve 
with k = 1 except for the 8-11 min section which 
was concave with k = ¼.  Refer to the 
manufacturer’s instructions for the gradient 
curve equations and meaning of k.  Buffer A was 
H2O, buffer B was 250 mM NaOH, and buffer C 
was 1 M Na-acetate. The reference electrode 
was utilized in pH mode. The column 
temperature was 30°C, and the flow-rate was 
250 L/min. Amino acid standards including 
Hyl and Hyp were diluted to 25 M for each 
amino acid prior to injection of 20 L. The 
retention time (5.7 min) of Glc-O-Hyl was 
determined using a [14C]Glc-O-Hyl standard. 
Fractions covering the region of Glc-O-Hyl 
elution were collected after passage through a 
carbohydrate membrane desalter (Thermo-
scientific) utilizing a Dionex reagent free 
controller (Thermo-scientific).  Collected 
fractions were then analyzed by direct infusion 
mass spectrometry using a TriVersa NanoMate 
HD system (Advion BioSciences) connected to a 
quadrupole-TOF mass spectrometer (QTOF G2, 
Waters).  
 
RESULTS 
Mimivirus L230 is Similar to Human 
Lysyl-Hydroxylase and Collagen Galactosyl-
transferase Enzymes – The Mimivirus ORF 
L230 was identified as a potential collagen 
modifying enzyme because of sequence 
similarity to the human ColGalT GLT25D1 at 
the amino terminus and homology to a human 
lysyl hydroxylase PLOD1 at the carboxy 
terminus (Fig. 1). The L230 amino terminus 
shares 27.7% amino acid identity and 61% 
similarity with GLT25D1 over a stretch of 285 
amino acids. At the carboxy terminus, L230 has 
35% amino acid identity and 68% similarity 
with PLOD1 over a stretch of 388 amino acids 
(Fig. S1). 
Mimivirus L230 and Mimivirus 
Collagen Transcripts are Expressed Together 
During Infection – The possible role of L230 as 
a collagen modifying enzyme is relevant 
considering that the Mimivirus genome encodes 
seven collagen-like genes (24). In fact, Northern 
blot analysis of Mimivirus gene expression in 
infected Acanthamoeba polyphaga culture 
confirmed the co-expression of L230 with the 
seven Mimivirus collagen genes L71, R196, 
R239, R240, R241, L668, L669 by the late 
phase of the lytic infection (Fig. 2). This finding 
indicates that L230 is produced at the same stage 
of the viral life cycle as its putative substrates. 
L230 is a Bifunctional Lysyl 
Hydroxylase and Collagen Glycosyltransferase 
– The L230 protein was expressed in E. coli with 
an N-terminal His10-tag and purified by Ni2+ 
affinity chromatography (Fig. S2). To determine 
if L230 is enzymatically active, lysyl 
hydroxylase activity toward the peptide acceptor 
substrate (GDK)4 (Table S1) was assayed. L230 
showed substantial activity toward this peptide 
confirming indications from homology shared 
with the PLOD1 enzyme that L230 is a lysyl 
hydroxylase (Fig. 3A). Similarly, to assess the 
putative collagen glycosyltransferase activity of 
L230, we assayed the transfer of carbohydrates 
to bovine collagen type I as an acceptor 
substrate. This experiment confirmed the activity 
of L230 as a glycosyltransferase. Unlike the 
animal ColGalT enzymes GLT25D1 and 
GLT25D2, L230 preferentially catalyzed the 
transfer of Glc to collagen (Fig. 3B) identifying 
L230 as a glucosyltransferase. 
L230 is a Collagen O-
Glucosyltransferase Defining a Novel Collagen 
Glycoform – The product of the L230 
glycosyltransferase reaction was further 
analyzed after alkaline hydrolysis to determine 
the structure of the resulting glycoconjugate. 
The corresponding amino acid analysis of 
modified bovine collagen type I by HPLC 
pointed to the presence of [14C]Glc-O-Hyl, 
indicating that L230 attaches Glc directly to Hyl 
(Fig. 4). The core Gal-O-Hyl structure is found 
in all animal collagens, from sponge (30), to 
birds (31) to mammals (4,32). Therefore, the 
Glc-O-Hyl core represents a novel form of 
collagen glycosylation. 
L230 is Substrate Promiscuous Toward 
Both Viral and Human Collagen Substrates – 
The acceptor substrate specificity of L230 was 
further investigated in a lysyl hydroxylase assay 
using six collagen-like peptides as acceptor 
substrates. In addition to the (GDK)4 peptide 
(Fig. 3), we tested a standard (GIK)4 peptide 
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(33) and four peptides derived from the 
Mimivirus collagen ORFs L71 (labeled L71a), 
R196, R240 and L669 (Table S1). The highest 
activity was observed with the R240 peptide 
(Fig. 5A) featuring a mix of hydrophobic, 
hydrophilic, positively and negatively charged 
residues.  More work is required to delineate the 
exact substrate preference of L230 since at 
present we cannot discern any obvious pattern of 
acceptor substrate specificity. The collagen 
glucosyltransferase (ColGlcT) activity of L230 
was also assayed on three Hyl containing 
peptides (Table S1). The peptide labeled L71b 
was from the Mimivirus ORF L71 collagen-like 
protein, while peptides Col2A1, and ADPQ were 
from human collagen 2A1 and adiponectin, 
respectively. Mirroring the result with the lysyl 
hydroxylase activity, L230 exhibited substrate 
promiscuity, as shown by the ability of the 
enzyme to glycosylate Hyl in both Mimivirus-
like and human-like sequences (Fig 5B). By 
comparison, the human collagen galactosyl-
transferase GLT25D1 showed similar activities 
toward the three acceptor peptides (Fig. 5C). 
However, the human enzyme had a somewhat 
lower tolerance for the Mimivirus acceptor 
peptide featuring GDK repeats, which are not 
common in animal collagens. 
The L230 Lysyl Hydroxylase and 
Glucosyltransferase Activities are Separable – 
To determine whether the lysyl hydroxylase and 
glycosyltransferase domains of L230 can 
function independently from each other, we 
prepared separate mutants in each domain and 
assayed the corresponding lysyl hydroxylase and 
ColGlcT activity (Fig. 6A and B). Mutation of 
two conserved residues (H825S/D827A) in the 
lysyl hydroxylase domain (Fig. S1) abrogated 
the lysyl hydroxylase activity while having no 
effect on the ColGlcT activity (Fig. 6A). Many 
glycosyltransferases possess DXD motifs that 
chelate a metal ion cofactor.  We began by 
attempting to mutate the putative DXD motif 
(10) in the glycosyltransferase domain 
(E106A/D107A/D108A, E106A, D107A) (Fig. 
S1). Unfortunately, these mutant proteins did not 
express stably in E. coli. Most mutations in the 
N-terminal domain of L230, namely L78K, 
H80A, D97A/D99A, and D131A in addition to 
the aforementioned DXD mutants yielded 
unstable proteins when expressed in E. coli. The 
substitution D250A in the glycosyltransferase 
domain did not affect the expression level and 
stability of L230 but led to decreased ColGlcT 
activity while leaving the lysyl hydroxylase 
activity intact (Fig. 6B). 
L230 Sequentially Hydroxylates and Gluco-
sylates Collagen Substrates in vitro – Next, we 
assessed whether the L230 enzyme is capable of 
performing both the lysyl hydroxylase and 
ColGlcT activities in the same assay. As 
acceptor substrate, we utilized His10-tag purified 
Mimivirus L71 collagen expressed in E. coli. As 
shown by the incorporation of [14C]Glc into L71 
collagen (Fig. 6C), L230 first hydroxylated Lys 
in L71 and then glucosylated the newly formed 
Hyl. By comparison, the H825S/D827A mutant 
enzyme which possesses wild-type ColGlcT 
activity (Fig. 6A) but lacks the lysyl hydroxylase 
activity was unable to produce glucosylated L71 
in the double activity assay. Similarly, the 
reaction of L230 with L71 in the presence of 
UDP-[14C]Glc but absence of 2-oxoglutarate 
failed to produce glycosylated L71. The lack of 
activity with the H825S/D827A mutant enzyme 
confirms the complete absence of Hyl in the E. 
coli produced L71 substrate prior to 
modification by L230. Thus, these experiments 
demonstrate that L230 is a bifunctional enzyme, 
capable of sequentially hydroxylating and 
glycosylating collagen. 
Post-translationally Modified Collagen 
is Present in Mimivirus – Considering the dual 
activity of L230 and the expression of the L230 
gene during Mimivirus replication, we 
investigated whether Hyl and Glc-O-Hyl could 
be identified in Mimivirus proteins. To this end, 
Mimivirus was isolated from the supernatant of 
infected A. polyphaga and the viral protein was 
subjected to alkaline hydrolysis and analyzed. 
Using the Dionex AAA-Direct amino acid 
analysis system with pulsed amperometric 
detection, we could readily detect Hyl but no 
Glc-O-Hyl in the virus extract (Fig. 7). Fractions 
covering the region of Glc-O-Hyl elution were 
collected and analyzed by mass spectrometry. 
However, we did not see any ion products 
corresponding to Glc-O-Hyl in these fractions. 
Taken together, our findings show that 
Mimivirus possesses the machinery to post-
translationally modify collagens in vivo, thereby 
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establishing the existence of modified collagen 
in Mimivirus virions. 
 
DISCUSSION 
We have shown that Mimivirus L230 is 
a bifunctional lysyl hydroxylase and 
glycosyltransferase enzyme involved in the post-
translational modification of collagen. This is 
the first report of a collagen glycosylating 
enzyme in viruses and of hydroxylysine outside 
of animals. It is interesting to note that an animal 
collagen glucosyltransferase activity has been 
reported for human lysyl hydroxylase 3 (34). 
Importantly, the description of Mimivirus L230 
activity reveals a novel type of collagen core 
glycosylation in nature. 
The seven Mimivirus collagen proteins 
are dominated by Gly-X-Y repeats, but are, in 
contrast to mammalian collagens, poor in proline 
content. The in vitro activity of a viral prolyl 
hydroxylase toward peptides substrates has been 
reported in Paramecium bursaria Chlorella 
virus-1 (35). However, the presence of 
hydroxyproline in viral proteins has not yet been 
established, nor is it known whether this viral 
enzyme is a collagen modifying hydroxylase. 
While Hyp is generally required for thermal 
stability of animal collagen (36), there are 
instances, such as in worms from deep sea 
hydrothermal vents, where the typical role of 
Hyp is replaced by glycosylated Thr (37-38). 
Whether or not Mimivirus collagens form triple 
helices, and whether triple-helix formation is 
Hyp dependent or is dependent on some other 
residue type is as yet unknown. Additionally, the 
role of collagen in Mimivirus biology remains 
an open question. It seems reasonable to 
speculate that there is a structural function for 
these proteins, possibly contributing to the dense 
layer of fibrils reported to cover the viral capsid 
(39). These fibrils could play a role in providing 
the virus resistance to the environment where 
viral interaction with host cells may be an 
infrequent occurrence. 
The apparent ease with which giant 
viruses accumulate and potentially disseminate 
genes from various organisms (40-45) begs the 
question of what role Mimivirus may have 
played in the evolution of collagen biology. The 
presence of collagens in animals and near 
absence in other organisms suggests that 
collagen biology was an animal adaptation. The 
disparity between animal collagen sequences 
and typical Mimivirus sequences, including a 
paucity of Pro in the viral collagens raises 
potential questions about the origin of collagen 
biology. The possibility exists that collagens did 
not originate with animals, but first emerged 
from a microbial source earlier in evolution. 
Nevertheless, the ability of viruses such as 
Mimivirus to transfer genes from one organism 
to another signifies a potential role in the 
evolution of collagen biology irrespective of the 
ultimate origins of collagens in nature.  
There are other potential glycosyl-
transferase enzymes in the Mimivirus genome 
including L137, L193 and L363, which are 
homologous to bacterial glycosyltransferases. 
The L179 ORF is homologous to an archaea 
glycosyltransferase, and the L373, R654, and 
R655 ORFs are homologous to animal 
glycosyltransferases (24,46-47). Whether or not 
the Glc residue on Hyl in Mimivirus collagens is 
further elongated, possibly by one of these 
enzymes, is still an unanswered question.  
Indeed, our analysis did not identify Glc-O-Hyl 
in Mimivirus protein extracts whereas Hyl was 
readily detectable. It was recently reported that 
Mimivirus experiences a significant reduction in 
genome size after 150 passages through an 
amoebal host (48). While the ORFs of several 
putative Mimivirus glycosyltransferases and one 
of the collagen genes were either deleted or 
disrupted in this reduced genome, L230 was 
maintained as were the remaining six collagen 
genes. 
Mimivirus ColGlcT is the very first 
microbial collagen glycosyltransferase 
described. It is also the first viral protein shown 
to be a bifunctional enzyme involved in the post-
translational modification of collagen. This work 
confirms the presence of post-translationally 
modified collagen domains in proteins outside 
the three currently accepted domains of life.
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FIGURE LEGENDS 
 
FIGURE 1. 
Homology of Mimivirus L230 with human GLT25D1 and PLOD1 enzymes. A schematic representation 
of the two regions of homology is shown at top. Corresponding sections of the L230 amino and carboxy 
terminal protein sequence with the greatest degree of homology to the human GLT25D1 and PLOD1 
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enzymes respectively, is shown below. Identical residues are shaded in black. The protein sequence 
intervening between the two regions of homology is shown as a line connecting the two boxes. An 
alignment containing the complete sequences is available in Fig. S1. 
 
FIGURE 2. 
Expression of Mimivirus L230 and collagen genes during Acanthamoeba polyphaga infection. The 
Northern blots show the transcript levels of L230 and of the collagen L71, R196, R239, R240, R241, 
L668, and L669 genes at different time points of infection. 
  
FIGURE 3. 
Mimivirus L230 possesses collagen lysyl hydroxylase and glucosyltransferase activities. 
Assays containing all necessary assay components are represented by open bars, negative control assays 
lacking acceptor substrates are represented by filled bars. (A) Lysyl hydroxylase assay with L230 enzyme 
and the (GDK)4 peptide acceptor substrate.  2-oxoglutarate indicates that 2-[14C]oxoglutarate is the 
source of radioactivity in the assay. The error bars show the standard error of the mean from six 
measurements out of two independent experiments. (B) Collagen glycosyltransferase activity of L230 
enzyme and bovine collagen type I as acceptor substrate. UDP-Glc: UDP-[14C]Glc donor substrate, UDP-
Gal: UDP-[14C]Gal donor substrate. UDP-GlcNAc: UDP- [14C]GlcNAc donor substrate, UDP-GalNAc: 
UDP-N-[14C]GalNAc donor substrate, UDP-GlcA: UDP-[14C]GlcA donor substrate. The error bars show 
the standard error of the mean from four measurements out of two independent experiments. 
 
FIGURE 4. 
The L230 glucosyltransferase product is Glc-O-Hyl. A bovine collagen type I substrate was modified 
with [14C]Glc by L230 and then hydrolyzed with NaOH for amino acid analysis using reverse phase 
HPLC. The amino acids were derivatized with Fmoc and their elution from the column monitored by 
fluorescence detection. (A) Amino acid standards in the region of interest. Peaks are labelled with the 
single letter amino acid code. Hyl: hydroxylysine; Hyp: hydroxyproline; GG-Hyl: Glc-1,2-Gal-1,O-
hydroxylysine standard; G-Hyl: Gal-1,O-hydroxylysine standard. The Fmoc peak which co-elutes with 
threonine is labelled with an asterisk. Fluorescence intensity of the Fmoc labelled amino acids is shown. 
(B) Alkaline hydrolysate from bovine collagen type I modified with [14C]Glc by L230. [3H]Val and 
[14C]Tyr were added to the sample as internal standards. 
 
FIGURE 5. 
Acceptor substrate specificity of L230. (A) L230 lysyl hydroxylase activity toward six peptide acceptor 
substrates (Table S1). Negative control assays (Neg) without acceptor substrate are shown as black bar. 
The error bars show the standard error of the mean of six assays from two independent experiments. (B) 
L230 ColGlcT activity toward three peptide acceptor substrates containing Hyl (Table S1). Mock assays 
lacking the recombinant enzymes are shown as black bars. The error bars show the standard error of the 
mean of four assays from two independent experiments. (C) GLT25D1 ColGalT activity towards the 
same three peptide acceptor substrates containing Hyl as in panel B (Table S1). Mock assays lacking the 
recombinant enzymes are shown as black bars. The error bars show the standard error of the mean of four 
assays from two independent experiments. 
 
FIGURE 6. 
Bifunctional L230 lysyl hydroxylase and glucosyltransferase domains. (A) Lysyl hydroxylase assays 
showing that the H825S/D827A double mutant exhibits disrupted lysyl hydroxylase activity while the 
wild-type (WT) enzyme and the D250A mutant show normal lysyl hydroxylase activity. Acceptor 
substrate in the assays was the R240 peptide (Table S1) from Figure 5A. Inset: Coomassie blue stained 
SDS-PAGE of purified WT and mutant proteins. (B) ColGlcT assays showing that the WT and the 
H825S/D827A mutant L230 enzymes possess normal ColGlcT activity, while the D250A mutant L230 
shows decreased ColGlcT activity. The acceptor substrate is bovine collagen type I. In both panels, the 
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standard error of the mean of six assays from two independent experiments is shown. (C) Combined lysyl 
hydroxylase and ColGlcT assays. The transfer of [14C]Glc on Mimivirus L71 collagen substrate was 
measured in the presence of L230 or L230(H825S/D827A) lacking lysyl hydroxylase activity. The 
absence of 2-oxoglutarate in the assay buffer prevented the transfer of [14C]Glc to L71 collagen. These 
data show the mean and standard error of the mean of four assays from two independent experiments. 
 
FIGURE 7. 
Hyl detection in Mimivirus protein extracts. Amino acids were detected by pulsed amperometric 
detection. Peaks are labelled with amino acid single letter codes. The retention time of Glc-O-Hyl is 
indicated by an arrow. The asterisk indicates an unidentified peak. 
11
12
Figure 2
13
Figure 3
14
Figure 4
15
Figure 5
16
Figure 6
17
Figure 7
18
